Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
06/30/2011 | US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device |
06/30/2011 | US20110160128 Corin for Treating Obesity and Diabetes |
06/30/2011 | US20110159128 Alcohol metabolism enhancer and alcoholic beverage |
06/30/2011 | US20110159127 Extract of toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof |
06/30/2011 | US20110159118 Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes |
06/30/2011 | US20110159112 Recombinant alpha-fetoprotein and compositions thereof |
06/30/2011 | US20110159104 Microemulsion |
06/30/2011 | US20110159088 ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS |
06/30/2011 | US20110159087 Crosslinked Polymers |
06/30/2011 | US20110159086 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion |
06/30/2011 | US20110159083 Nanoparticles for protein drug delivery |
06/30/2011 | US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
06/30/2011 | US20110159055 Nutritional supplement for use under physiologically stressful conditions |
06/30/2011 | US20110159045 Method of treating dysglycemia and glucose excursions |
06/30/2011 | US20110159010 Compositions and Methods for Decreasing Type III Deiodinase Activity to Modulate Adiposity and Blood Glucose Levels |
06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
06/30/2011 | US20110158980 Methods to treat and screen for agents to treat obesity |
06/30/2011 | US20110158979 Genetic component of complications in type 2 diabetes |
06/30/2011 | US20110158976 Enzymes for pharmaceutical use |
06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
06/30/2011 | US20110158962 Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
06/30/2011 | US20110158961 Materials and methods relating to cell based therapies |
06/30/2011 | US20110158935 Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents |
06/30/2011 | US20110158932 Methods And Compositions For The Treatment of Hyperlipidemia |
06/30/2011 | US20110158910 Microparticles comprising polymers with thioester bonds |
06/30/2011 | DE102006053637B4 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New fluoro-substituted 1,4-benzothiepine-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use |
06/30/2011 | DE102006053635B4 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use |
06/30/2011 | CA2785674A1 Novel 3-hydroxy-5-arylisothiazole derivative |
06/30/2011 | CA2785268A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof |
06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
06/30/2011 | CA2784179A1 Emulsion composition |
06/29/2011 | EP2339351A1 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
06/29/2011 | EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability |
06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
06/29/2011 | EP2338484A1 Metabolic imprinting effects of structured lipids |
06/29/2011 | EP2337569A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
06/29/2011 | EP2337564A1 A method for combating adverse effects arising from antipsychotic treatment |
06/29/2011 | EP2114937B1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals |
06/29/2011 | EP1849774B1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
06/29/2011 | EP1414314B1 Composition for lowering blood cholesterol |
06/29/2011 | EP1322315B1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
06/29/2011 | CN201880198U Treating bag of peripheral nerves of diabetes mellitus |
06/29/2011 | CN1972932B Compounds for treating dyslipidemia |
06/29/2011 | CN1850112B Polyethylene glycol electrolyte oral solution |
06/29/2011 | CN1427889B Hybrid cells obtainable from antigen presenting cells |
06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
06/29/2011 | CN102112483A Solid forms of (2s, 3r, 4r, 5s, 6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3, 4, 5-triol and methods of their use |
06/29/2011 | CN102112475A Imidazopyridine and related analogs as sirtuin modulators |
06/29/2011 | CN102112465A Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
06/29/2011 | CN102112134A Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity |
06/29/2011 | CN102112127A Escalating dosing regimen for effecting weight loss and treating obesity |
06/29/2011 | CN102112126A Low dose topiramate/phentermine compostion and methods of use thereof |
06/29/2011 | CN102112122A Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
06/29/2011 | CN102108372A Preparation method and application of beta-glucan |
06/29/2011 | CN102108097A Novel GLP-1 (glucagon-like peptide-1) derivative |
06/29/2011 | CN102107006A Coupling medicament for treating diabetes mellitus and medicinal application thereof |
06/29/2011 | CN102106957A Chinese medicinal composition for treating hyperlipidemia |
06/29/2011 | CN102106939A Quality control method for extract concentrated liquor of condensed pills of six ingredients with rehmannia root |
06/29/2011 | CN102106932A Medicament for treating diabetic foot |
06/29/2011 | CN102106927A Fat-clearing pressure-reducing tea |
06/29/2011 | CN102106922A Chinese medicine for treating diabetes mellitus |
06/29/2011 | CN102106898A Composition for treating impaired glucose tolerance and preparation method thereof |
06/29/2011 | CN102106897A Active ammonia peptide nutrient and preparation method thereof |
06/29/2011 | CN102106895A Composition with function of regulating blood fat |
06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
06/29/2011 | CN102106875A Method for extracting water-soluble alpha-glucosidase inhibitor |
06/29/2011 | CN102106871A Compound calcium supplement injection for pets |
06/29/2011 | CN102106870A Method for preparing high-density calcium carbonate granules |
06/29/2011 | CN102106840A Gemfibrozil capsule and preparation method thereof |
06/29/2011 | CN102106837A Glipizide sustained release tablets and preparation method thereof |
06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
06/29/2011 | CN102106834A Pioglitazone hydrochloride chewable tablets and preparation method thereof |
06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
06/29/2011 | CN102106818A Isoliquiritigenin micro-emulsion composition |
06/29/2011 | CN102106816A Resveratrol nanometer preparation and preparation method thereof |
06/29/2011 | CN102106587A Preparation method and application of extracts from natural plants |
06/29/2011 | CN102106417A Dandelion health-preservation tea |
06/29/2011 | CN101904862B Water-soluble vitamin composition freeze-drying preparation for injection |
06/29/2011 | CN101869692B Curcumin self-microemulsion and preparation method thereof |
06/29/2011 | CN101843831B Chinese medicament for treating diabetic cardiopathy |
06/29/2011 | CN101791352B Phenformin-containing traditional Chinese and western medicine composition |
06/29/2011 | CN101791350B Glibenclamide-containing traditional Chinese and western medicine composition |
06/29/2011 | CN101708237B Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof |
06/29/2011 | CN101607051B Traditional Chinese medicine composition for losing weight and preparation method thereof |
06/29/2011 | CN101591374B Steroid compound, preparation method thereof, medicinal composition containing compound and application of compounds |
06/29/2011 | CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
06/29/2011 | CN101549045B Traditional Chinese medicine preparation for treating diabetes and preparation method thereof |
06/29/2011 | CN101548757B Insoluble dietary fiber of raisin tree and preparing method thereof |
06/29/2011 | CN101507738B Preparation method of Shu Xuening injection |
06/29/2011 | CN101491532B Erigeron breviscapus eye-preparation and preparation method thereof |
06/29/2011 | CN101485865B Chinese medicine fat-reducing plaster |
06/29/2011 | CN101301314B Technique for producing liver extract |
06/29/2011 | CN101233231B Anti-obesity agent and anti-obesity food |